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Key Points
• This chapter focuses on human and animal data linking undernutrition in utero (i.e., placental 
insufficiency, nutrient restriction, maternal low protein) with long-term hepatic dysfunction in 
postnatal life.
• Undernutrition in utero influences lipid homeostasis, gluconeogenesis, insulin sensitivity, drug 
metabolism, and overall growth leading to liver fibrosis and long-term symptoms of the metabolic 
syndrome.
• Some of the direct mechanisms linking undernutrition in perinatal life to hepatic dysfunction 
include hypoxia and epigenetic influences (i.e., DNA methylation, posttranslational histone modi-
fications, and microRNAs).
• Rapid postnatal catch-up growth can indirectly augment hepatic ER stress leading to impaired 
insulin signaling and alterations in microRNAs in the liver.
• Animal studies have indicated that intervention in perinatal life with essential nutrients, hormones, 
or modulators of nuclear receptors can rescue hepatic gene expression and may prevent the long- 
term metabolic deficits associated with the undernourished liver.
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IGF-1 Insulin growth factor 1
IUGR Intrauterine growth restriction
JMJD Jmj domain-containing histone demethylation protein
LDL Low-density lipoproteins
LP Low protein
LXR Liver X receptor
miRs MicroRNAs
MMP2 Matrix metalloproteinase 2
MNR Maternal nutrition restriction
MPR Maternal protein restriction
pAkt1 (Ser473) Phospho Akt1 (serine 473)
Pck1 Phosphoenolpyruvate carboxykinase 1 (soluble)
pEIF2α Phospho-eukaryotic translation initiation factor 2
PND Postnatal day
PPAR Peroxisome proliferator-activated receptor
SGA Small for gestational age
SMAD4 SMAD family member 4
TGFB1 Transforming growth factor β1
TUDCA Tauroursodeoxycholic acid
UPR Unfolded protein response
VEGF Vascular endothelial growth factor
 Introduction
The liver plays a critical role in mammals for metabolism, digestion, detoxification, storage, protein 
production, and immunity. Given the role of the liver in cholesterol, fatty acid, and glucose homeosta-
sis, it is not surprising hepatic dysfunction underlies several of the symptoms (i.e., hypercholesterol-
emia, obesity, glucose intolerance) characterizing the metabolic syndrome [1, 2]. The surge in the 
incidence of the metabolic syndrome worldwide is of great concern considering that it raises the risk 
of developing cardiovascular disease (CVD) by ~20-fold, and CVD is responsible for 1 out 2.9 deaths 
in the United States [3–6]. In addition to the metabolic syndrome, impaired liver health and function 
also can lead to liver fibrosis (and the end-stage cirrhosis), which is estimated to contribute up to 45% 
of deaths in the developed world [7, 8]. Liver fibrosis is a major predictor for diabetes, overall liver 
failure, portal hypertension, and liver cancer [9–11]. Since diet (i.e., “Western diet”) is a major con-
tributor to defects in liver function and ultimately liver fibrosis or CVD, current therapeutic strategies 
are aimed at lifestyle modifications (i.e., physical activity and healthy eating) and/or pharmaceutical 


















































reducing the risk of CVD, the long-term dependency on them can be dangerous for the liver. For 
example, statins can reduce the risk of ischemic heart disease by up to 60%; however, the existence of 
statin-induced rhabdomyolysis and hepatitis-associated liver failure emerges in some patients [16]. 
Clearly additional studies are warranted for hepatic disease prevention versus treatment. A major 
preventative strategy is in recognizing the early origins of adult disease so that efficacious interven-
tions can be targeted to prevent long-term defects in liver function.
 Maternal Undernutrition and Impaired Hepatic Function: Clinical Evidence
Over 25 years ago, Professor David Barker revealed that adverse in utero events can permanently alter 
physiological processes leading to the metabolic syndrome [17]. The early evidence that an impair-
ment of liver size and/or function was involved came from the fact that there was a strong correlation 
between reduced abdominal circumference at birth with elevated total and LDL cholesterol in adult-
hood [18]. Secondly, intrauterine growth restriction (IUGR), caused by either placental insufficiency 
or maternal malnutrition, often results in asymmetric organ development whereby there is a reduction 
in the growth of less essential organs such as the liver, lungs, and kidneys [19, 20]. Thirdly, there is a 
strong inverse relationship between birth weight and obesity or glucose intolerance; both under the 
regulation of the liver [21–24]. It is noteworthy that the majority of these links to metabolic disease 
arose from large population-based studies whereby under nutrition in utero (i.e., due to famine) was 
the major factor leading to impaired fetal growth [21, 25–28].
Postpartum, the major factor influencing this inverse relationship between low birth weight and 
metabolic disease is nutrition-induced accelerated growth in neonatal life, which leads to an earlier 
onset of the symptoms of the metabolic syndrome [25, 29–31]. Barker explained this phenomenon with 
the “predictive adaptive response” hypothesis, which suggests that “adverse events during development 
induce adaptations suited for survival in a similar predictive environment but can become maladaptive 
if a mismatch to the predictive environment occurs, leading to a thrifty phenotype” [32, 33]. Since 
IUGR leads to major decreases in fetal liver development, it seems conceivable that the liver has the 
most to gain in growth during postnatal life [19, 20]. Animal models of IUGR support that the under-
nourished liver undergoes rapid postnatal catch-up growth leading to further metabolic dysfunction, 
but there is evidence from human studies as well [34–36]. For example, infants born small for gesta-
tional age (SGA) undergo hypersomatotropism as early as 4 days as a result of increased circulating 
insulin growth factor 1 (IGF-1) produced by the liver [37]. Elegant studies by Singhal et al. have also 
demonstrated that low birth weight infants with rapid postnatal growth (due to growth- promoting for-
mula diets) exhibited a higher LDL/HDL ratio, likely derived from impaired cholesterol homeostasis 
in the liver [38]. While future noninvasive imaging studies are warranted to tract liver development 
(i.e., liver growth, lipid composition) in IUGR infants long-term, animal models of maternal undernu-
trition have shed great light into the mechanisms underlying the fetal programming of the liver. More 
importantly, by elucidating some of the underlying mechanisms involved, new pharmaceutical and 
dietary intervention strategies can be employed to prevent these defects in liver function.
 Uterine Ligation or Ablation Model of Undernutrition and Long-Term 
Hepatic Function
As previously mentioned, IUGR can occur due to placental insufficiency which occurs in about 8% of 
pregnancies [39, 40]. Animal studies have demonstrated that placental insufficiency-induced IUGR 
leads to decreases in oxygenation and substrate availability for the fetus [41–43]. Therefore, the uter-
ine ligation or uterine ablation serves as an excellent model for examining idiopathic IUGR and the 












































short- and long-term effects on liver function. Both models lead to decreased birth weight and lower 
liver to body weight ratios [35, 44]. In the guinea pig, uterine ablation led to a greater incidence of 
hepatic perisinusoidal or periportal fibrosis in 5-month offspring with increased expression of profi-
brogenic markers including TGFβ1, MMP2, and SMAD4 [44]. In rats, uterine ligation leads to devel-
opment of the metabolic syndrome in the offspring including type 2 diabetes, dyslipidemia, and 
hypertriglyceridemia [45–47]. Interestingly, many of these symptoms were reciprocated into the F2 
generation [48]. These metabolic deficits exist, in part, due to altered glucose transporter expression, 
impairment of fatty acid metabolism, increased glucocorticoid activity, augmented glucose produc-
tion, and blunted insulin suppression all within the liver [45, 47, 49–51]. These offspring also exhib-
ited decreased hepatic and circulating insulin growth factor 1 (Igf-1) which is critical for insulin 
function, glucose metabolism, and growth [52]. While other models of maternal dietary-induced 
IUGR led to hypercholesterolemia in postnatal life, uterine ligation appears to have no effect on cho-
lesterol homeostasis unless the offspring were challenged with a high-fat diet in postnatal life [34, 53, 
54]. Although this animal model is physiologically relevant to idiopathic IUGR, it is distinct from 
dietary-induced undernutrition as it leads to direct decreases in both oxygen and nutrients to the fetus. 
Other exclusive dietary models are essential in understanding the contribution of maternal malnutri-
tion alone on long-term hepatic function and disease.
 Maternal Nutrient Restriction (MNR) Model of Undernutrition
Human and animal studies of food restriction during pregnancy confirm that maternal undernourish-
ment leads to IUGR depending upon the timing (pre- vs postconception) and severity of the insult [28, 
29, 55–57]. Moreover, like models of uterine ligation, fetal liver growth from MNR dams is compro-
mised at birth followed by rapid postnatal catch-up growth [36, 55, 58]. However, with models of 
MNR, the impact of a decrease in maternal and placental weight during pregnancy must also be taken 
into consideration [55, 59]. Sheep and rat studies have demonstrated that MNR leads to glucose intol-
erance and insulin insensitivity, along with greater hepatic lipid and glycogen content in the offspring 
[58, 60]. The impaired glucose tolerance in MNR sheep offspring is attributed, in part, to increased 
circulating cortisol and augmented hepatic PEPCK expression in MNR offspring [60]. In contrast to 
offspring of uterine ligation, MNR offspring with catch-up growth exhibited increases in Igf-1 which 
the authors attribute is associated with decreased longevity, but not necessarily metabolic disease [58].
 Maternal Protein Restriction (MPR) Model of Undernutrition
Placental insufficiency in humans often leads to protein (and amino acid) deficiencies in the fetus, 
which are critical for fetal growth [61, 62]. Therefore, the MPR model is a relevant model to study 
placental insufficiency-IUGR as it leads to asymmetric IUGR, without any effects on maternal weight 
gain or food intake [22, 63]. Moreover, MPR offspring have decreases in fetal liver weight at birth and, 
depending on the timing of protein restoration, display liver and whole body catch-up growth despite 
no differences in food intake [34, 64]. Remarkably, MPR offspring, more predominantly in males, 
exhibit several symptoms of the metabolic syndrome including glucose intolerance, visceral obesity, 
hypercholesterolemia, and hypertension [34, 65–69]. The glucose intolerance is attributed to augmented 
gluconeogenesis (e.g., G6Pase, 11β-HSD1), diminished glucokinase expression, decreased pAkt1 
(Ser473), and decreased glucagon receptor in the livers of MPR offspring [64, 67, 70, 71]. With respect 
to lipids, MPR male offspring with catch-up growth show increases in circulating hepatic cholesterol 
due to decreases in the expression of Cyp7a1, the critical enzyme in cholesterol metabolism [34]. 













































exhibit increases in hepatic Cyp3a and Cyp2c11 expression and activity influencing long-term drug 
metabolism (i.e., statins) in these offspring [72]. As testosterone is a major substrate for these Cyp 
enzymes, it may explain why MPR male offspring have lower circulating testosterone levels, and con-
sequentially, the long-term sexual dimorphism which exists in this model [68]. Similar to uterine-ligated 
offspring, MPR offspring with catch-up growth have decreases in hepatic Igf-1; however, the decrease 
in Igf-1 is mainly attributed to the effects of protein restriction during lactation [63]. All in all, the MPR 
model truly reinforces the main principle of Barker’s “predictive adaptive response” given that when 
there is no nutritional mismatch in postnatal life, MPR offspring do not exhibit any decreases in choles-
terol catabolism, insulin sensitivity, or drug metabolism in the liver [34, 64, 72].
 Direct Mechanisms Linking Maternal Undernutrition and Adverse 
Metabolic Outcomes
While human and animal studies have certainly established the strong links between an undernour-
ished in utero environment and metabolic deficits in the offspring, we only just beginning to unravel 
the direct and indirect molecular events involved. Interestingly, one of the major direct drivers of 
altered hepatic gene expression and function short- and long-term would be hypoxia. While it is not 
surprising that uterine ligation directly leads to hypoxia in the liver, maternal undernutrition alone in 
guinea pigs also led to increases in the expression of markers of hypoxia (EPO, EPO receptor, VEGF) 
in the fetal liver and kidney [35, 73]. In uterine ligation studies, decreases in oxygenation reduced 
hepatic mitochondrial oxidative phosphorylation and further led to oxidative stress in young rat off-
spring [35, 47]. Collectively, this explains the increased hepatic gluconeogenesis and impaired insulin 
signaling exhibited in this young offspring.
Epigenetic forces have also been implicated to play a direct and sustaining role in the fetal program-
ming of the liver. Epigenetic mechanisms, which include direct DNA methylation, posttranslational 
histone modifications, and microRNAs (miRs), influence the long-term expression of a gene by alter-
ing the ability of the transcriptional machinery to interact with the chromatin environment. Elegant 
studies in the baboon fetus have demonstrated that 70% undernutrition during pregnancy led to aug-
mented hepatic gluconeogenesis associated with both increased Pck1 mRNA and decreases in the 
methylation of CpG dinucleotides of the Pck1 promoter [59]. Moreover, uterine ligation has been 
shown to directly increase DNA methylation in the promoter of hepatic Igf-1 at birth and that this per-
sists into the F2 generation even when F1 IUGR offspring are adequately nourished [48, 74]. 
Interestingly, in this study, supplementation of the diet in the F1 IUGR offspring with folic acid, cho-
line, betaine, vitamin B12, and other essential nutrients prevented the methylation of the Igf-1 promoter 
in the F2 generation along with symptoms of the metabolic syndrome [48]. However, caution is neces-
sary in the overall interpretation of these studies given undernutrition-induced alterations in DNA 
methylation can vary between sexes and within different CpG islands of the same promoter [74].
Posttranslational histone modifications, which include methylation, acetylation, phosphorylation, 
ubiquitination, and ADP-ribosylation of histones, serve as another epigenetic mechanism to influence 
long-term gene expression by perinatal undernutrition. This is evident when maternal dietary protein 
is restricted during pregnancy and lactation leading to long-term hypercholesterolemia as a result of 
decreased expression of hepatic Cyp7a1, the critical enzyme involved in cholesterol catabolism [34]. 
Remarkably, the histone modifications involved in MPR-induced silencing the expression of Cyp7a1 
promoter, namely, increased trimethylation and decreased acetylation of histone H3 [lysine 9, 14], are 
sustained from 3 weeks to 4 months in postnatal life [34]. The origin of these histone modifications is 
due, in part, to MPR-mediated decreased in Jmjd2a and Jmjd2c, demethylases involved in removing 
trimethyl groups of histone H3 [lysine 9]. It is noteworthy that while both male and female MPR 
offspring exhibited decreased Cyp7a1 expression at 3 weeks, female MPR offspring at 4 months are 
protected from the posttranslational histone modifications silencing the Cyp7a1 promoter. MPR has 
















































also been demonstrated to lead to long-term posttranslational histone modifications (e.g., decreased 
histone H3 acetylation [lysine 9, 14] silencing the expression of the hepatic liver X receptor (LXRα) 
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Fig. 9.1 The effect of maternal low-protein diet in utero on the in vivo transcriptional and epigenetic regulation of the 
LXRα transcriptional start site (−135 to +144 bp) at 4 months of age. (a) Binding of RNA polymerase II to the LXRα TSS, 
(b) trimethylation of histone H3 lysine 4, (c) acetylation of histone H3 lysine 9 and 14, and (d) trimethylation of histone 
H3 lysine 9. Primers were designed based on sequencing from Ensembl. Livers were immunoprecipitated with antibodies 
specific to RNA polymerase II, trimethylated histone H3 [K4], acetylated histone H3 [K9, 14], and trimethylated histone 
H3 [K9]. Quantification was performed using qRT-PCR (Sso-Fast EvaGreen) with primers specific to the proposed LXR 
element sites. The relative amount of immunoprecipitated genomic DNA was normalized to total genomic DNA. Data are 
represented as arbitrary values using the ∆∆Ct method. Results are expressed as the mean ± standard error (SEM). * = 





augmented expression of hepatic gluconeogenic enzymes (e.g., G6Pase and 11β-HSD1) contributing 
to glucose intolerance [67].
MiRs, which consist of short, noncoding RNA molecules of 20–25 nucleotides in length, can also 
act in an epigenetic manner to regulate gene expression by repressing the translation of proteins or 
decreasing messenger RNA (mRNA) stability. MPR during pregnancy and lactation has been demon-
strated to increase the expression of miR-29a, miR-29b, and miR-29c in the liver by 3 weeks and 
4 months of age which silences the expression of Igf-1 and decreases body weight [63]. Interestingly, 
protein restriction during lactation alone had a greater effect to augment the miR-29 family and sup-
press Igf-1, while restoration of maternal dietary proteins in MPR offspring at birth prevented miR-29 
repression of Igf-1 [63]. In the guinea pig, uterine ligation in pregnancy led to decreases in hepatic 
miR-146a expression in the 5-month offspring, concomitant with an increase in its target profibrotic 
gene, SMAD4 [44]. Further studies are warranted to investigate how the expression of miRs in the 
liver is altered by perinatal undernutrition via direct (i.e., regulation of 5′-UTR of miR promoters) and 
indirect (i.e., ER stress) mechanisms [75].
 Indirect Mechanisms Linking Maternal Undernutrition and Adverse 
Metabolic Outcomes: The Contribution of Catch-Up Growth
In several animal models of maternal undernutrition leading to metabolic disease, often the changes 
in hepatic gene expression do not occur directly at the time of the perinatal insult but manifests later 
in life [58, 64, 72]. This may be attributed to long-term global changes (e.g., epigenetic mechanisms), 
initiated by the perinatal environment, which precedes the eventual alterations in gene function. For 
example, in MPR offspring whereby increases in trimethylation of histone H3 [lysine 9] silencing the 
promoter of Cyp7a1 was present in 3 week and 4 month offspring, alterations in histone methylation 
were not yet occurring in embryonic life [34]. However, the stage was beginning to be set as MPR- 
mediated decreases in the fetal expression of histone demethylases in the liver were apparent [34].
The more probable reason for indirect effects of a perinatal undernutrition and long-term altera-
tions in hepatic gene expression is rapid postnatal catch-up growth. As previously mentioned, in 
humans postnatal catch-up growth can accelerate the onset and exacerbate the symptoms of metabolic 
disease in low birth weight children [25, 29–31]. Given the undernourished neonatal liver undergoes 
major catch-up growth postpartum, it is quite conceivable that the “stress” of active hepatocyte growth 
and replication during this period of time may confer detrimental metabolic deficits which only arise 
after this window of recovery. The leading mechanism likely involved in this rapid growth-triggered 
process is endoplasmic reticulum (ER) stress.
ER stress occurs when perturbation in the function or homeostasis of the ER leads to luminal accu-
mulation of misfolded or unfolded proteins [64]. Many known triggers of ER stress include impaired 
disulfide bond formation, compromised Ca2+ homeostasis, low amino acids, hypoxia, decreased 
N-linked glycosylation, increased lipid load, and greater oxidative stress. In response to ER stress, the 
unfolded protein response (UPR) tries to restore ER homeostasis by attenuating protein translation 
(i.e., increased pEIF2α) while at the same time increasing the expression of chaperone proteins 
involved in refolding proteins to alleviate the ER. However, if ER stress persists, apoptosis is initiated 
leading to alterations in gene expression and cell function. In MPR offspring with postnatal catch-up 
growth (due to restoration of proteins at weaning), the livers at 4  months exhibit ER stress (i.e., 
increased pEIF2α) attributed to impaired insulin sensitivity (e.g., decreased pAkt1[Ser473] despite 
the fact that the food intake is similar (Fig. 9.2, LP2) [63, 64]. Conversely, if there is no catch-up 
growth, protein translation is enhanced with higher hepatic insulin sensitivity (Fig. 9.2, LP1) [64]. 
The low-protein diet itself does not appear to be playing a direct role given alterations in the ER stress 
pathway were not detected in the fetal liver. Given oxidative stress is present in the undernourished 
liver, and that the “mismatch” in the nutritional environment likely leads to lipid overload and/or 
















































impaired disulfide bond formation, it is apparent that these triggers during perinatal life, coupled with 
postnatal catch-up growth, may initiate the cascade leading to chronic ER stress [35, 47]. It is note-
worthy that in a perinatal rat model of nicotine exposure leading to postnatal catch-up growth and 
dyslipidemia, ER stress was also evident in the adipose tissue of 6-month offspring [76]. Aside from 
directly influencing hepatic gene expression and function, augmented ER stress in the liver may also 
alter epigenetic mechanisms such as miRs. For example, activation of ER stress has been demon-
strated to induce miR-29a which is known to silence Igf-1 and pAkt-1 (Ser473) [75]. It is noteworthy 
that miR-29a is increased in 4-month MPR offspring with catch-up growth and ER stress, coupled 
with decreased Igf-1 an pAkt-1 (Ser473) [63, 64]. An overview of the direct and indirect mechanism 
involved in the nutritional programming of the perinatal liver is illustrated in Fig. 9.3.
 The “Plastic Liver”: Intervening in Early Life to Prevent  
Long-Term Metabolic Dysfunction
From fetal to neonatal life, the liver undergoes extensive growth, differentiation, and remodeling cre-
ating an ideal window for intervention given its plasticity. During fetal life, the liver is considered 
mainly hematopoietic, while in postnatal life is considered more hepatocyte-like [77]. This may 
explain why certain perinatal nutritional insults altering postnatal gene expression are differentially 
altered in fetal life [67, 72]. By mid-gestation in rodents, the liver bud is formed containing progenitor 







































































































































Fig. 9.2 The effect of maternal low-protein dietary regimes on hepatic phosphorylated eIF2α (Ser51) protein levels at 
4 months of age. The effect of (a) LP1 (low protein all life) and (b) LP2 (low-protein pregnancy and lactation) dietary 
regimes on phosphorylated protein kinase B (Akt1) at serine 473, Akt1, phosphorylated eukaryotic initiation factor 2 α 
(eIF2α) at serine 51, and eIF2α protein levels in the livers of male offspring at postnatal day 130. Relative p-Akt1 
(S473), Akt1, p-eIF2α (S51), and eIF2α protein levels were determined using Western blot analysis. Total protein was 
isolated and p-Akt1 (S473), Akt1, p-eIF2α (S51), and eIF2α protein were detected on a Western blot using p-Akt1 
(S473), Akt1, p-eIF2α (S51), and eIF2α primary antibody. Their protein levels were quantified using densitometry and 
normalized to that of β-actin protein levels. Results were expressed as the mean ± SEM. *, significant difference 
(P < 0.05); n = 5–6 for control and n = 6–7 for LP1 and LP2 group, where each n represents a single offspring derived 




















the liver mass triples due to extensive proliferation [78, 79]. After birth in rodents, there is a greater 
transition from fetal to adult hepatocytes accompanied by high rates of replication, neogenesis, and 
apoptosis [79]. The human liver develops in a similar pattern, although the majority of liver differen-
tiation occurs in prenatal life [80]. It is estimated that the postnatal rodent liver at 3 weeks is equiva-
lent to the human liver at the third trimester. Regardless of the species, the perinatal liver is undergoing 
extensive remodeling and is subject to alterations by environmental cues during this period. These 
cues can consist of alterations in nutrition, hormones/cell signaling, epigenetic forces, and/or by the 
actions of pharmaceuticals.
Fig. 9.3 Overview of the direct and indirect mechanisms underlying how undernutrition in utero impairs liver function 
from neonatal to adult life. Direct pathways altered by maternal undernutrition are indicated by red solid arrows, while 
indirect pathways affected by placental insufficiency and postnatal catch-up growth are indicated by red dashed arrows. 
Neonatal intervention strategies are illustrated in cyan arrows









From a nutrition standpoint, several studies have investigated the role of vitamins, folic acid, 
and proteins to reverse the effects of undernutrition on hepatic health. In a maternal diabetes model 
leading to IUGR and decreased liver weight in Sabra rats, supplementation of vitamins C and E in 
pregnancy prevented decreases in fetal liver weight, but not total bodyweight [81]. The IUGR-
associated lipid peroxidation in these fetal livers was also significantly reduced due to maternal 
vitamin supplementation attributed to increases in superoxide dismutase antioxidant activity [81]. 
Given its role a methyl donor for DNA methylation, intervention studies with folic acid show 
promise in reversing some of the epigenetic mechanisms associated with the undernourished liver. 
Elegant studies by Lillycrop demonstrated that administration of folic acid during MPR pregnancy 
reversed the decreases in DNA methylation to the promoters of PPARα and GR and subsequently 
diminished the MPR increases in their fetal gene expression. But with respect to DNA methylation, 
the benefits of folic acid appear to be promoter specific given periconceptional intake of folic acid 
(400 μg/day) led to an increase in DNA methylation of hepatic insulin growth-like factor 2 and, 
subsequently, low birth weight [82]. As mentioned previously, introduction of a combination of 
nutrients (i.e., folic acid, vitamin B12) to the diet of IUGR offspring has multigenerational effects 
given the F2 generation did not exhibit impairments in hepatic and lipid homeostasis [48]. The use 
of the bile acid tauroursodeoxycholic acid (TUDCA) could be considered as a promising safe 
therapeutic agent in neonatal life given its ability to reduce ER stress (e.g., protein refolding) and 
consequentially improve liver insulin sensitivity [83]. With regard to protein supplementation, the 
beneficial effects of restoring maternal proteins also appear to be very promoter specific in the 
liver. In rats, restoring maternal proteins at birth prevents long-term decreases in hepatic choles-
terol metabolism (e.g., Cyp7a1) and Igf-1 but leads to greater expression of genes involved in 
gluconeogenesis (e.g., G6Pase and 11β-HSD1) [34, 63, 67]. These studies illustrate the complexity 
between the length of the nutritional insult, epigenetics, and catch-up growth on long-term hepatic 
gene expression.
Hormones and nuclear receptors have promise in reversing the adverse effects of undernutrition on 
hepatic dysfunction. One of the best examples is with the use of the glucagon-like peptide-1 (Glp-1) 
analog, exendin-4 (Ex-4). Neonatal administration of Ex-4 to uterine-ligated IUGR offspring pre-
vented the long-term development of hepatic oxidative stress and insulin resistance [47]. It also 
exerted beneficial effects on the pancreatic β cells via increases in the expression of Pdx-1 [84]. 
Another hormone and antioxidant, melatonin, has been demonstrated in increase umbilical blood flow 
during gestation in sheep, but it did not rescue growth restriction in undernourished ewes [85]. 
Targeting nuclear receptors may have a more sustained impact given their widespread roles in 
 influencing endocrine function along with glucose and lipid homeostasis. Female IUGR offspring 
treated with agonists to the lipid-sensing nuclear receptor PPARγ have long-term insulin-sensitizing 
effects, although hypoglycemia was also exhibited [86]. Given the role of the liver X receptor (LXRα) 
in regulating cholesterol, glucose, and fatty acid homeostasis, altering LXR activity in early life could 
impair several symptoms of the metabolic syndrome. A pilot study using the LXR agonist (GW3695) 
during neonatal life (PND5-15) in MPR offspring led to decreased total cholesterol levels concomi-
tant with increased LXRα and Cyp7a1 by 3 weeks of age [87]. An overview of the known neonatal 
interventions is summarized in Fig. 9.3.
Regardless of the success of particular intervention strategies in animal models, caution must be 
approached in assessing its overall efficacy. The intervention must be examined in the context of the 
species examined and how the timing of intervention relates to liver development (e.g., plasticity) 
between species. The impact of the intervention on epigenetic mechanisms must also be considered to 
determine its sustainability long-term but, more importantly, on the specificity (or lack thereof) to 
particular target promoters. For the time being, the safer approach may be in general dietary imple-





















































In response to maternal undernutrition and placental insufficiency, the fetal liver takes a huge hit with 
respect to development and growth. Consequentially, the undernourished neonatal liver has the most 
to gain in postnatal life leading to accelerated catch-up growth. However, both developmental events 
end up being detrimental to long-term liver function. The present review illustrates the direct epigen-
etic mechanisms underlying the aberrant expression of hepatic genes in malnourished offspring which 
persists into adulthood. Hypoxia in the neonatal liver also plays a role in driving some of these epi-
genetic mechanisms along with increased oxidative stress. With ensuing rapid catch-up growth in 
postnatal life, this places a burden on the normal growth trajectory of the liver leading to onset of ER 
stress. This culminates in further metabolic dysfunction such as ER-mediated insulin insensitivity in 
the liver. In this chapter, nutritional, hormonal, and pharmaceutical interventions early in life are cited 
which mitigate the effects of undernutrition on hepatic gene expression and function short- and long- 
term. However, further studies are warranted to address the safety, specificity, and sustainability of 
these interventions to the whole organism. Until that time, more conventional nutritional steps are 
necessary to reduce postnatal catch-up growth of IUGR offspring in the hope to reduce global effects 
(e.g., ER stress) on the recovering liver.
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